B1.1.7 and E484K variants

Study suggests Pfizer’s COVID-19 vaccine less effective against South African variant

Britain and many other countries have begun rolling out the Pfizer-BioNTech vaccine to try to stem the spread of the pandemic disease
When the scientists added all the key mutations found in the B1.1.7 and E484K variants, they found the efficacy of the vaccine was affected

By Reuters · 02 February 2021